Inmaculada López-Montesinos

Pompeu Fabra University — Spain

Medicine · Health Sciences

15h-index885citations59works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(17), Antibiotic Resistance in Bacteria(14), Antibiotic Use and Resistance(11), Long-Term Effects of COVID-19(10), SARS-CoV-2 and COVID-19 Research(6)

Publications54 total

Preventing resistance development in infections by OXA β-lactamase-producing <i>Pseudomonas aeruginosa</i> : correlating clinical outcomes with hollow-fibre model input
Journal of Antimicrobial Chemotherapy·2025Open Access
Giants in infectious diseases: Prof. Jose M. Miró’s translational research in infective endocarditis
Clinical Microbiology and Infection·2025
Inpatient versus outpatient management of community-acquired acute skin and soft tissue infections. Clinical outcomes and factors associated with eligibility for early discharge
BMC Infectious Diseases·2025Open Access
Prevalence, risk factors for and trends in faecal colonisation by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) in the community in Spain: A cross-sectional study and meta-analysis
Enfermedades infecciosas y microbiologia clinica (English ed )·2025
ZINC ADJUVANT TREATMENT IN SARS-COV-2: A RANDOMIZED CLINICAL TRIAL
2025Open Access
Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial
Infectious Diseases and Therapy·2025· 4 citedOpen Access
20 A comparative analysis of patients with acute skin and soft tissue infections: Hospitalization <i>versus</i> outpatient management
British journal of surgery·2025Open Access
Prevalence, risk factors for and trends in faecal colonisation by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) in the community in Spain: A cross-sectional study and meta-analysis
Enfermedades Infecciosas y Microbiología Clínica·2024· 1 cited
Standing on the shoulders of giants: heroes and heroic studies paving the way forward in clinical microbiology and infectious diseases
Clinical Microbiology and Infection·2024· 2 cited
Clinical Microbiology and Infection will recognize excellent research by early-career scientists
Clinical Microbiology and Infection·2024· 3 cited
A case–control study of the clinical and economic impact of infections caused by Carbapenemase-producing Enterobacterales (CPE)
Infection·2024· 1 citedOpen Access
Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
Pneumonia·2024· 1 citedOpen Access
Corrigendum to “European society of clinical microbiology and infectious diseases guidelines on diagnosis and treatment of brain abscess in children and adults” [Clin Microbiol and Infect 30(1) (2024 Jan) 66–89 Doi: 10.1016/j.cmi.2023.08.016]
Clinical Microbiology and Infection·2024· 5 citedOpen Access
Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant <i>Pseudomonas aeruginosa</i>
Microbiology Spectrum·2023· 1 citedOpen Access
“European Society of Clinical Microbiology and infectious Diseases Guidelines on diagnosis and treatment of brain abscess in children and adults” Author's reply
Clinical Microbiology and Infection·2023· 3 citedOpen Access
6. ENDOCARDITIS TROMBÓTICA NO BACTERIANA COMO ETIOLOGÍA DE ICTUS MÚLTIPLE CARDIOEMBÓLICO EN ADENOCARCINOMA DE PULMÓN METASTÁSICO
Revista Española de Cardiología·2023
European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults
Clinical Microbiology and Infection·2023· 112 citedOpen Access
Safety and Efficacy of Favipiravir in COVID-19 Patients with Pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
Research Square (Research Square)·2023Open Access
Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae
Antibiotics·2022· 6 citedOpen Access
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence
Antibiotics·2022· 12 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Juan Pablo Horcajada(28), Luisa Sorlí(19), Sílvia Gómez-Zorrilla(18), M. Montero(16), Robert Güerri‐Fernández(13), Santiago Grau(12), Xavier Durán(7), Elena Sendra(7), Xavier Nogués(6), Natalia García‐Giralt(6), Núria Prim(6), Joan Gómez‐Junyent(5), Katharina Last(5), Isabel Arnau-Barrés(5), Carla López-Causapé(5), Sònia Luque(5), Mar Arenas-Miras(5), Jacob Bodilsen(4), Julio Pascual(4), Sandra Domene-Ochoa(4)